{
    "code": "51059872",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059872",
    "time": "2023-03-10 04:20:38",
    "許可證字號": "衛部藥製字第059872號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/02\/26",
    "發證日期": "107\/02\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05105987200",
    "中文品名": "芙苷寧膜衣錠300毫克",
    "英文品名": "Fofnir F.C. Tablets 300mg",
    "適應症": "1.本品適用於與其他抗反轉錄病毒藥物合併使用於成人HIV-1感染之治療。\r\n2.本品適用於與其他抗反轉錄病毒藥物併用，治療對NRTI產生抗藥性，或因毒性反應無法使用第一線藥物治療之HIV-1感染的12歲(含)至18歲小兒患者。\r\n3.本品用於治療具有病毒複製及活動性肝臟發炎証據之慢性B型肝炎的成人與12歲及以上小兒患者。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE) 2-1000錠AL-AL鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "TENOFOVIR DISOPROXIL FUMARATE",
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "0402601200  中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口182之1號",
    "主製造廠": [
        {
            "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818003510",
            "成分名稱": "TENOFOVIR DISOPROXIL FUMARATE",
            "含量描述": "(eq. to Tenofovir Disoproxil.....245mg)",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛部藥製字第059872號_藥物外觀-108-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=002&Type=10"
        },
        {
            "title": "Fofnir F.C. Tablets 300 mg圖檔-107-04-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "10.衛部藥製字第059872號-仿單1081219更新-109-01-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=003&Type=9"
        },
        {
            "title": "Fofnir F.C. Tablets 300 mg In (3)-108-01-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=002&Type=9"
        },
        {
            "title": "衛部藥製字第059872號_鋁箔外觀外盒-108-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=003&Type=8"
        },
        {
            "title": "Fofnir F.C. Tablets 300 mg La-107-04-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=002&Type=8"
        },
        {
            "title": "Fofnir F.C. Tablets 300 mg Box-107-04-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059872&Seq=001&Type=8"
        }
    ]
}